The clinical nutrition market has grown significantly in the last fifteen years, bringing it to the exciting and emerging field that it is today. Many large food and healthcare companies are moving into the medical foods area, notably Nutricia, Nestle and Abbott Laboratories.
The major driving factors for the market are decreasing birth rate driving up aging of populations, aging population nutritional issues such as energy restriction, food insecurity, obesity and sarcopenia etc., and increased disease diagnosis. Other factors affecting the growth of the market are increased preterm birth deaths in high income countries. The major diseases responsible for the growth of the market are cardiovascular diseases, cancer, dementia and diabetes. Some of the mergers and acquisitions also acted as a triggering factor for the market, for example. In 2008, Nestle acquired CM&D Medical food startup in specialized nutrition. However, market is highly constrained because of medical foods category is tightly regulated by the FDA- oral/tube and the reimbursement issues.
In 2008, 206,000 patients received Enteral nutrition by tube compared to 231,000 receiving Parenteral nutrition. Talking about major market share holders, Abbott holds the first position, followed by Nestle. Danone and Fresenius-Kabi have no presence in the US but together hold a further 22% of the global market. US reported new product launches of approximately 156 in this segment. A brief analysis of the number of patents reflects Nutricias patents around products composed of Probiotics and targeted towards infants. Abbott Laboratories also appear to focus on milk and infant products on this landscape. Diabetes is the most commonly targeted disease and related patents are clustered around a peak that focuses on treating metabolic disorders.
US are the major market share holder in this region, followed by Canada. Excess annual health care expenditure was $860 and $933 for every man and woman with sarcopenia in US in 2000, which is estimated to increase more because of changing lifestyle and increasing aging population.
North America Clinical nutrition market is segmented by type of applications( Infant, child, adult, sports nutrition and therapeutic nutrition) by Ingredients( vitamins and amino acids, minerals and glucose), by type of services( diarrhea, cancer, diabetes, renal diseases, protein mal-absorption etc.), by route of administration( oral, tube feeding and parentral) and by country wise( US, Canada and Mexico).
The key players in the market are focussed on expansion of the business by launching new products and extending the product line. Mergers and acquisitions of small and medium sized manufacturers to enter in overseas market is another strategy adopted by multinational players. The major players in the market are Abbott Healthcare, Nestle Health Sciences, Danone clinical nutrition, Fresenius Kabi, Nutricia etc.
What the Report Offers
1) Market Definition Asia-Pacific Clinical nutrition market mark along with identification of key drivers and restraints for the market.
2) Market analysis for the Asia-Pacific Clinical nutrition market, with region specific assessments and competition analysis on a global and regional scale.
3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4) Extensively researched competitive landscape section with profiles of major companies along with their share of markets.
5) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Reasons for Buying this Report
1)For gaining an exhaustive understanding of the worldwide market for Asia-Pacific Clinical nutrition.Would be of assistance in providing a comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade
2) An ideal opportunity for industry consultants, and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered
3) Wide-ranging information provided about the leading market players and the major strategies adopted by them.
Please note: As this product is updated at the time of order, dispatch will be 72 hours from the date the order and full payment is received
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Technology Overview
5.3 New Developments
5.4 Industry Value-Chain Analysis
5.5 Product Life-Cycle Analysis
5.6 Product Benchmarking
5.7 Investment Analysis
5.8 Porter’s Five Forces
5.8.1 Bargaining Power of Suppliers
5.8.2 Bargaining Power of Consumers
5.8.3 Threat of New Entrants
5.8.4 Threat of Substitute Products and Services
5.8.5 Competitive Rivalry within the Industry
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS DROC
6.1 Market Drivers
6.1.2 INCREASE IN AGING POPULATION
6.1.3 INCREASING AVAILABILITY OF INNOVATIVE PRODUCTS
6.2 Market Restraints
6.2.1 VOLATILITY OF THE MARKET
6.2.2 REGULATORY PRESSURE
6.3 Key Challenges
6.4 Current Opportunities in the Market
7.1 By Application
7.1.4 SPORTS MEDICINE
7.1.5 THERAPEUTIC NUTRITION
7.2 BY INGREDIENTS
7.2.1 AMINO ACIDS
7.2.2 VITAMINS & MINERALS
7.3 BY SERVICES
7.3.1 PROTEIN MALDIGESTION
7.3.3 FOOD ALLERGIES
7.3.7 SHORT-BOWEL SYNDROME
7.3.8 GI-TRACT IMPAIRMENT
7.3.9 ACUTE LUNG INJURY (ALI)
7.3.10 ACUTE RESPIRATORY DISTRESS (ARDS)
7.4 BY ROUTE OF ADMINISTRATION
7.5 By Geography
7.5.1 North America (NA)
126.96.36.199 United States
188.8.131.52 Rest of North America
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 New Product Launches
8.3 Agreements, Collaborations & Partnerships
9. Key Vendor Analysis
9.1 ABBOTT NUTRITION
9.2 NESTLE HEALTH SCIENCES
9.3 FRESENIUS KABI
9.4 BAXTER HEALTHCARE
9.5 BRAUN MELSUNGEN AG
10. Analyst Outlook for Investment Opportunities
11. Future Outlook of the Market